![Leslie P. Counsens](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Leslie P. Counsens
Keine laufenden Positionen mehr
Profil
Dr. Leslie Counsens is Scientific Director-Protein Therapeutics at EpiVax, Inc.
Dr. Counsens was previously employed as an Assistant Professor by Boston University.
She received her doctorate degree from Brown University.
Ehemalige bekannte Positionen von Leslie P. Counsens
Unternehmen | Position | Ende |
---|---|---|
Boston University | Corporate Officer/Principal | - |
EpiVax, Inc.
![]() EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Leslie P. Counsens
Brown University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
EpiVax, Inc.
![]() EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Health Technology |